ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Colorectal Cancer

Endometrial Cancer trials near Charlotte, NC, USA:

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...

Enrolling
Endometrial Cancer
Endometrioid Endometrial Cancer
Drug: nab-sirolimus

Phase 2

Aadi Bioscience

Charlotte, North Carolina, United States and 8 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Charlotte, North Carolina, United States and 168 other locations

advanced solid tumors. Subjects with all histologic types of solid tumors are eligible for the escalation and dose-finding portion ...

Active, not recruiting
Endometrial Cancer
Solid Tumor
Drug: TPST-1495 twice daily
Drug: TPST-1495 once daily or on intermittent schedule

Phase 1

Tempest Therapeutics

Huntersville, North Carolina, United States of America and 10 other locations

A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients wit...

Enrolling
Non Small Cell Lung Cancer
Ovarian Cancer
Drug: DR-0202

Phase 1

Dren Bio

Huntersville, North Carolina, United States and 9 other locations

study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: AZD8205
Drug: AZD8205 and AZD5305 (saruparib)

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Charlotte, North Carolina, United States and 65 other locations

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Charlotte, North Carolina, United States and 206 other locations

in participants with select loco-regionally recurrent solid tumors or metastatic solid tumors where curative or standard treatment ...

Enrolling
Neoplasms
Drug: Nelistotug
Drug: Belrestotug

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Charlotte, North Carolina, United States and 23 other locations

Locations recently updated

This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced ...

Enrolling
Advanced Solid Cancer
KRAS G12D Mutation
Drug: ARV-806

Phase 1, Phase 2

Arvinas
Arvinas

Huntersville, North Carolina, United States and 3 other locations

Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors...

Enrolling
Advanced Solid Tumors
Advanced Breast Cancer
Drug: ETX-636 dose expansion in combination with fulvestrant
Drug: ETX-636 dose escalation in combination with fulvestrant

Phase 1, Phase 2

Ensem Therapeutics

Huntersville, North Carolina, United States of America and 2 other locations

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...

Enrolling
Ovarian Neoplasms
Biliary Tract Neoplasms
Drug: Cetuximab
Drug: Cisplatin

Phase 1, Phase 2

Lilly
Lilly

Charlotte, North Carolina, United States and 49 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems